These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1908751)

  • 21. FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
    Bajetta E; Di Bartolomeo M; Carnaghi C; Buzzoni R; Mariani L; Gebbia V; Comella G; Pinotti G; Ianniello G; Schieppati G; Bochicchio AM; Maiorino L
    Br J Cancer; 1998 Apr; 77(7):1149-54. PubMed ID: 9569054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma.
    Hsieh CH; Hsu CL; Wang CH; Liaw CC; Chen JS; Chang HK; Yang TS; Chang JW; Lin YC; Liau CT; Tsang NM; Chang JT; Ng SH; Wang HM
    Biomed J; 2013; 36(5):229-36. PubMed ID: 24225189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
    Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
    Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
    Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective study of FAM regimen in 38 patients with advanced gastric cancer.
    Ridolfi R; Casadei Giunchi D; Cortesi C; Maltoni M; Ravaioli A; Amadori D
    Tumori; 1984 Aug; 70(4):375-9. PubMed ID: 6548054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gastric cancer. UFTP Study Group].
    Sato A; Hasegawa K; Kurihara M; Takahashi M; Akazawa S; Fukuyama Y; Koizumi W; Hayakawa M; Sasai T; Kimura K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1355-62. PubMed ID: 7668870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)".
    Flechtner H; Queisser W; Heim ME; Henss H; Arnold H; Fritze D; Herrmann R; Fritsch H; Fritz M; Trux FA
    Onkologie; 1987 Apr; 10(2):67-71. PubMed ID: 3108738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial.
    Cascinu S; Galizia E; Labianca R; Ferraù F; Pucci F; Silva RR; Luppi G; Beretta GD; Berardi R; Scartozzi M
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):37-43. PubMed ID: 20821330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UFT plus cisplatin for advanced gastric cancer.
    Kurihara M
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):106-8. PubMed ID: 9348580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer. A preliminary report.
    Oster MW; Park Y
    Cancer; 1983 Jan; 51(2):203-5. PubMed ID: 6821812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
    Haim N; Epelbaum R; Cohen Y; Robinson E
    Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
    Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A current overview of chemotherapy in advanced gastric cancer].
    Ogawa M
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2161-8. PubMed ID: 2660747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Complete response in a case of unresectable gastric cancer with a combination of tegafur, 5-fluorouracil and mitomycin C].
    Sasaki Y; Sasaki J; Ito T; Nehashi Y
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2793-5. PubMed ID: 3137891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
    Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
    Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancer.
    Creagan ET; Chang M; Long HJ; Rubin J
    Head Neck Surg; 1986; 8(3):153-8. PubMed ID: 3091535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC).
    De Lisi V; Cocconi G; Tonato M; Di Costanzo F; Leonardi F; Soldani M
    Cancer Treat Rep; 1986 Apr; 70(4):481-5. PubMed ID: 3516397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II multicentric trial of S-1 combined with 24 h-infusion of cisplatin in patients with advanced gastric cancer.
    Iwase H; Shimada M; Tsuzuki T; Horiuchi Y; Kumada S; Haruta J; Yamaguchi T; Sugihara M; Ina K; Kusugami K; Goto S
    Anticancer Res; 2005; 25(2B):1297-301. PubMed ID: 15865081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.